INTERNATIONAL PATENT: JUNO THERAPEUTICS, INC., CENTURY THERAPEUTICS, INC. FILES APPLICATION FOR "GENETICALLY ENGINEERED CELLS HAVING ANTI-CD33 / ANTI-CD123 CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF"

GENEVA, Oct. 6 -- JUNO THERAPEUTICS, INC. (400 Dexter Ave. N.Suite 1200Seattle, Washington 98109), CENTURY THERAPEUTICS, INC. (25 North 38th St.11th FloorPhiladelphia, Pennsylvania 19104) filed a patent application (PCT/US2025/021590) for "GENETICALLY ENGINEERED CELLS HAVING ANTI-CD33 / ANTI-CD123 CHIMERIC ANTIGEN RECEPTORS, AND USES THEREOF" on Mar 26, 2025. With publication no. WO/2025/207795, the details related to the patent application was published on Oct 02, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WURMSER, Andrew Evan (c/o Bristol-Myers Squibb CompanyRoute 206 & Province Line ...